Our previous study demonstrated that XOR inhibition hinders contrast-induced acute kidney injury (AKI) by ameliorating oxidative stress through the activation of AMPK and its downstream signaling pathway15. This evidence concerns the gene PRKAA2 and acute kidney injury.